Catapult Venture Managers has invested £500,000 into Probe Scientific as part of a £1m funding round.
Probe Scientific is developing disposable blood sampling products to solve clinical problems and improve healthcare.
The Bedforshire-based company is said to have a substantial product pipeline based on its proprietary technologies and is seeking to commercialise this range.
MicroEye, Probe’s first product, allows for continuous, automated and real-time sampling without removing blood from the patient.
The device incorporates a semi-permeable membrane, which sits in the vein of a patient, and a biosensor located outside the body to measure blood characteristics such as glucose, potassium and urea levels.
Virgin Atlantic’s Flight100 saved 95 tonnes of CO2 in first SAF flight
Are dated government reports any longer credible??